MAPT and Alzheimer disease: Moreover, Aβ misfolding and aggregation is thought to precede tau misfolding and aggregation, although previous studies have shown amazing results in detecting AD even at the preclinical stage by biomarkers (CSF Aβ42/40, t-tau, and p181-tau) [59].